seedfolio Archived Investments
FUND 2 INVESTMENTS
Basilard has a novel mechanoporation device for non-viral ex-vivo transfection with greater efficiency and cell viability than electroporation.
Chronus is developing the first point-of-care device to measure both CBC and CMP in minutes at high accuracy and low cost. CBC and CMP account for 50% of all lab tests and $9b of market size.
Delpor’s platform delivers drugs at stable levels for up to 12 months from a single implant.
Hap10 is developing antibodies targeting haptens of inhibited KRAS12C. From the UCSF Labs of Charles Craik and Kevan Shokat.
Interface Bioscience uses AI and secret sauce to map the full metabolome of the human microbiome (skin and gut) and use this novel library and data to find novel immunomodulating agents. They are starting with eczema and then IBD.
Kinathera is developing a novel oral inhibitor of type 1 interferon to treat auto-immune diseases.
Leap has a revolutionary process to manufacture solar cells without wafers
Preview Medical is improving the diagnosis and treatment of prostate cancer
S2 Genomics is developing a device to process solid tissues into single-cells or nuclei for sequencing
Tiamat is using plants to produce mammalian proteins at low cost and high scale for cultured meats and biotech.
Xeno Biosciences is tackling the massive obesity epidemic with a revolutionary pill.
FUND 1b INVESTMENTS
Reprogram patient's immune cells within the patient, aka in vivo CAR-T
Repurposing a proven, potent NSAID into a topical treatment for arthritis.
Developing an anti-toxin (not antibiotic) to stop c. difficile in its tracks
Selling a novel sensing device for hydraulic systems to grealy reduce unplanned maintenance and fluid spills
Developing lab-grown meat with low-cost breakthroughs. Pork without pain.
Developing and selling a platform to allow health-care providers to remotely monitor patients using vendor-agnostic hardware
Nutritional system to prevent food allergies in children
None